3x3 or 2x4? [RSABE / ABEL]

posted by felipeberlinski – Brazil, 2014-10-22 16:20 (3466 d 23:59 ago) – Posting: # 13763
Views: 14,639

Dear friends

Reading a BE reccomendation of FDA I would like to know about your experience using two different designs.

Since the drug is a HVD:
Their reccomendation is to use a 3-sequence 3-period or a 2-sequence 4 period design.

Could anybody explain the main differences between them and when should I use each one? Go easy, I'm not a biostatistician :cool:

Thanks in advance


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,665 registered users;
88 visitors (0 registered, 88 guests [including 6 identified bots]).
Forum time: 16:20 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5